DIVERSIFIED HEALTHCARE TRUSTDHC

DIVERSIFIED HEALTHCARE TRUST Income Taxes Disclosure

10-KFiled Feb 24, 20263 min read
Income Taxes
Our provision for income taxes consists of the following:
 For the Year Ended December 31,
 202520242023
Current:   
Federal$1,147 $— $(168)
State596 467 613 
 1,743 467 445 
Deferred:   
Federal— — — 
State— — — 
 — — — 
Income tax provision$1,743 $467 $445 
The table below is a reconciliation of the statutory income tax rate to the effective tax rate for 2025, in accordance with the updated requirements of ASU 2023-09. See Note 2 for further information on the adoption of ASU 2023-09:
 
For the Year Ended December 31, 2025
 AmountPercent
Taxes at statutory U.S. federal income tax rate$(59,407)21 %
Nontaxable income60,554 (21.4)%
State and local income taxes, net of federal tax benefit (1)
596 (0.2)%
Effective tax rate$1,743 (0.6)%
(1)States taxes in Texas make up a majority (greater than 50%) of the tax effect in this category.
Income taxes paid (net of refunds) for the year ended December 31, 2025 were $1,776, with the majority of payments attributable to Texas state and federal taxes, in the amount of $626 and $1,150, respectively.
As previously disclosed, for the years ended December 31, 2024 and 2023, the following table reconciles the statutory income tax rate to the effective tax rate prior to the adoption of ASU 2023-09:
 For the Year Ended December 31,
 20242023
Taxes at statutory U.S. federal income tax rate21.0 %21.0 %
Nontaxable income(21.0)%(21.0)%
Federal excise tax— %0.1 %
State and local income taxes, net of federal tax benefit(0.1)%(0.2)%
Effective tax rate(0.1)%(0.1)%
Deferred income tax balances reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities in our consolidated balance sheets and the amounts used for income tax purposes and are stated at enacted tax rates expected to be in effect when taxes are actually paid or recovered. Significant components of our deferred tax assets
and liabilities were as follows:
 For the Year Ended December 31,
 20252024
Deferred tax assets:    
Deferred income$3,458 $2,388 
Fair market value adjustment(2,053)(1,862)
Other1,983 1,225 
Tax loss carryforwards110,013 102,940 
 113,401 104,691 
Valuation allowance(113,401)(104,691)
 — — 
Net deferred income taxes$— $— 
Because of our TRSs' history of losses, we are not able to conclude that it is more likely than not we will realize the future benefit of our deferred tax assets; thus we have provided a 100% valuation allowance as of December 31, 2025 and 2024. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our consolidated statements of comprehensive income (loss). As of December 31, 2025, our consolidated TRSs had net operating loss carry forwards for federal income tax purposes of approximately $424,755, which do not expire. As of December 31, 2025, we, excluding our subsidiaries, had net operating loss carry forwards for federal income tax purposes of approximately $933,931, which do not expire. In the normal course of business, income tax authorities in various income tax jurisdictions conduct routine audits of our income tax returns filed in prior years. Income tax years subsequent to 2021 may be open to examination in some of the income tax jurisdictions in which we operate.
Free Sentinel

Want the next DIVERSIFIED HEALTHCARE TRUST income taxes disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment DIVERSIFIED HEALTHCARE TRUST's next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Feb 25, 2025
2023Feb 26, 2024
2022Mar 1, 2023
2021Feb 24, 2022
2020Feb 25, 2021
2019Mar 2, 2020
2017Feb 27, 2018

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.

Other Available Disclosures

RevenueEarnings Per ShareFair ValuePP&ELeasesSegmentsDebtNew Standards